Target intelligence / Profile preview

Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (ALKBH3)

Target
ALKBH3
Molecular classification
Enzyme, Dioxygenase, AlkB family DNA/RNA demethylase
01

Overview

Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (ALKBH3) is a Fe(II)- and 2-oxoglutarate-dependent enzyme that demethylates specific alkylated bases in single-stranded DNA and RNA, particularly 1-methyladenosine (m^1A) and 3-methylcytidine (m^3C)[2][3][4]. In DNA, ALKBH3 repairs lesions caused by alkylating agents and helps maintain genomic integrity. In RNA, especially tRNA, it modulates modifications that affect translation efficiency, ribosome assembly, and tumor cell survival. ALKBH3 is highly expressed in several cancers, promoting cell proliferation, migration, invasion, and resistance to apoptosis. Its essential roles in nucleic acid repair and RNA biology, along with its frequent overexpression in tumors, make it a compelling therapeutic target in oncology[3][4][7].

Other names
ABH3DEPC1hABH3DEPC-1Alkylated DNA repair protein alkB homolog 3Prostate cancer antigen 1PCA1
02

Mechanism of action

Inhibition leads to accumulation of methylated DNA/RNA bases, causing DNA damage, reduced tRNA function, impaired translation, cell cycle arrest, apoptosis, and tumor suppression[4][5].

03

Biological functions

Nucleic acid demethylationDNA repairRNA modification (including tRNA and mRNA demethylation)Regulation of translationPromotion of cell proliferation and survival
04

Disease associations

Cancer (including prostate, lung, renal, urothelial carcinomas)
05

Safety considerations

Genotoxicity in normal tissuesOff-target effects (due to role in maintaining genome integrity)
06

Interacting drugs

No approved small molecule inhibitors in clinical use

1 more in the full profile.

07

Biomarkers

ALKBH3 overexpression (associated with poor clinical outcomes and aggressive prostate and other cancers)

Beyond the preview

Go deeper on Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (ALKBH3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (ALKBH3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call